Literature DB >> 9515837

Early release of proinflammatory cytokines after lung transplantation.

H Mal1, M Dehoux, C Sleiman, J Boczkowski, G Lesèche, R Pariente, M Fournier.   

Abstract

BACKGROUND: Systemic hypotension may complicate the early postoperative period after lung transplantation. A release of proinflammatory cytokines secondary to lung ischemia/reperfusion injury could be involved in the pathogenesis of this early hemodynamic failure (EHF). STUDY
OBJECTIVE: To assess prospectively whether the occurrence of EHF is associated with a release of cytokines in the systemic circulation.
DESIGN: Blood samples were taken daily during the first postoperative week in 26 patients who underwent a double or a single-lung transplantation. These patients were divided into three groups: 7 patients who experienced EHF and subsequently died (EHF group); 15 patients without EHF (control group); and 4 patients without EHF but with an identified sepsis (sepsis group). The serum levels of interleukin (IL)-1beta, tumor necrosis factor-alpha (TNF-alpha), IL-6, and IL-8 were compared among the three groups.
RESULTS: In the EHF group, the levels of each cytokine peaked at day 1 postoperatively. Cytokine levels at day 1 were significantly higher in the EHF group than in the control group (p<0.0006) or in the sepsis group (p<0.003 except for TNF-alpha).
CONCLUSION: We conclude that EHF is associated with a massive release of proinflammatory cytokines that could play a determinant role in the pathogenesis of this complication.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9515837     DOI: 10.1378/chest.113.3.645

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

1.  Immediate postoperative inflammatory response predicts long-term outcome in lung-transplant recipients.

Authors:  David J Hall; Maher Baz; Michael J Daniels; Edward Denmark Staples; Charles T Klodell; Lyle L Moldawer; Thomas M Beaver
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-07-19

Review 2.  Primary graft dysfunction.

Authors:  Yoshikazu Suzuki; Edward Cantu; Jason D Christie
Journal:  Semin Respir Crit Care Med       Date:  2013-07-02       Impact factor: 3.119

Review 3.  Lung transplantation and bronchiolitis obliterans: an evolution in understanding.

Authors:  B W McKane; E P Trulock; G A Patterson; T Mohanakumar
Journal:  Immunol Res       Date:  2001       Impact factor: 4.505

4.  First Experience With Extracorporeal Cytokine Adsorption Therapy After Lung Transplantation.

Authors:  Marine Peyneau; Luc de Chaisemartin; Dorothée Faille; Jonathan Messika; Hervé Mal; Yves Castier; Pierre Mordant; José Luis Carrasco; Sébastien Tanaka; Brice Lortat Jacob; Paola Ferrari; Xavier Arrault; Nadine Ajzenberg; Sylvie Chollet-Martin; Philippe Montravers; Alexy Tran-Dinh
Journal:  Transpl Int       Date:  2022-03-21       Impact factor: 3.782

5.  Plasma protein biomarkers for primary graft dysfunction after lung transplantation: a single-center cohort analysis.

Authors:  Lourdes Chacon-Alberty; Rupa S Kanchi; Shengbin Ye; Camila Hochman-Mendez; Daoud Daoud; Cristian Coarfa; Meng Li; Sandra L Grimm; Maher Baz; Ivan Rosas; Gabriel Loor
Journal:  Sci Rep       Date:  2022-09-27       Impact factor: 4.996

6.  Protection from pulmonary ischemia-reperfusion injury by adenosine A2A receptor activation.

Authors:  Ashish K Sharma; Joel Linden; Irving L Kron; Victor E Laubach
Journal:  Respir Res       Date:  2009-06-26

7.  Cytokine levels in pleural fluid as markers of acute rejection after lung transplantation.

Authors:  Priscila Cilene León Bueno de Camargo; José Eduardo Afonso; Marcos Naoyuki Samano; Milena Marques Pagliarelli Acencio; Leila Antonangelo; Ricardo Henrique de Oliveira Braga Teixeira
Journal:  J Bras Pneumol       Date:  2014 Jul-Aug       Impact factor: 2.624

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.